BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10915232)

  • 1. Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension.
    Kawano Y; Makino Y; Okuda N; Takishita S; Omae T
    Blood Press Monit; 2000 Jun; 5(3):181-5. PubMed ID: 10915232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients.
    Minami J; Ishimitsu T; Kawano Y; Matsuoka H
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):572-6. PubMed ID: 9673431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 24-hour blood pressure, heart rate, and autonomic nerve activity in hypertensive patients treated with cilnidipine or nifedipine retard.
    Minami J; Ishimitsu T; Kawano Y; Numabe A; Matsuoka H
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):331-6. PubMed ID: 9700998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine.
    Hamada T; Watanabe M; Kaneda T; Ohtahara A; Kinugawa T; Hisatome I; Fujimoto Y; Yoshida A; Shigemasa C
    J Hypertens; 1998 Jan; 16(1):111-8. PubMed ID: 9533424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trough-to-peak ratio and circadian blood pressure profile after treatment with once-daily extended-release diltiazem, 240 mg, in patients with mild-to-moderate essential hypertension.
    Coca A; Sobrino J; Soler J; Módol J; Palos MA; Mínguez A; Esqúe J; Plana J; Cases M; Closas J; de la Sierra A
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):316-22. PubMed ID: 9125668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate-lowering and -regulating effects of once-daily sustained-release diltiazem.
    Boden WE; Vray M; Eschwege E; Lauret D; Scheldewaert R
    Clin Cardiol; 2001 Jan; 24(1):73-9. PubMed ID: 11195610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension.
    Minami J; Numabe A; Andoh N; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
    Br J Clin Pharmacol; 2004 May; 57(5):632-9. PubMed ID: 15089817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blunted parasympathetic modulation in salt-sensitive patients with essential hypertension: evaluation by power-spectral analysis of heart-rate variability.
    Minami J; Kawano Y; Ishimitsu T; Takishita S
    J Hypertens; 1997 Jul; 15(7):727-35. PubMed ID: 9222940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity.
    Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P
    J Hypertens; 2007 Jan; 25(1):169-75. PubMed ID: 17143189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of diltiazem on lipid profiles and heart rate in hypertensive patients].
    Carré A; Joire JE; Mounier-Vehier C; Lequeuche B
    Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):221-6. PubMed ID: 12555384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension.
    Minami J; Kawano Y; Makino Y; Matsuoka H; Takishita S
    Br J Clin Pharmacol; 2000 Dec; 50(6):615-20. PubMed ID: 11136301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled comparison of diltiazem and amlodipine monotherapy in essential hypertension using 24-h ambulatory monitoring.
    Watts RW; Wing LM
    Blood Press; 1998 Jan; 7(1):25-30. PubMed ID: 9551874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diltiazem on sympathetic hyperactivity in patients with vasospastic angina as assessed by spectral analysis of arterial pressure and heart rate variability.
    Yamasaki F; Sato T; Sugimoto K; Takata J; Chikamori T; Sasaki M; Doi Y
    Am J Cardiol; 1998 Jan; 81(2):137-40. PubMed ID: 9591894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SD-3211, a novel benzothiazine calcium antagonist, alone and in combination with a beta-adrenoceptor antagonist, produces antihypertensive effects without affecting heart rate and atrioventricular conduction in conscious renal hypertensive dogs.
    Kageyama M; Nishimura K; Takada T; Miyawaki N; Yamauchi H
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):102-7. PubMed ID: 1708042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effect of diltiazem administered once and twice daily.
    Mooser V; Waeber B; Nussberger J; Brunner HR
    J Hum Hypertens; 1988 Dec; 2(4):257-60. PubMed ID: 3236328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration-time-dependent effects of diltiazem on the 24-hour blood pressure profile of essential hypertension patients.
    Kohno I; Iwasaki H; Okutani M; Mochizuki Y; Sano S; Satoh Y; Ishihara T; Ishii H; Mukaiyama S; Ijiri H; Komori S; Tamura K
    Chronobiol Int; 1997 Jan; 14(1):71-84. PubMed ID: 9042553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
    Harada K; Nomura M; Nishikado A; Uehara K; Nakaya Y; Ito S
    Circ J; 2003 Feb; 67(2):139-45. PubMed ID: 12547996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.